Furazolidone PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Furazolidone PCD pharma franchise company in India, offering a focused range of 4 Furazolidone formulations manufactured at WHO-GMP certified facilities. We supply consistent, DCGI-approved antimicrobial products to franchise partners and distributors who need dependable stock and district-wise monopoly support.
What is Furazolidone?
Furazolidone is a nitrofuran antimicrobial that interferes with bacterial enzyme systems and is active against several gastrointestinal pathogens. It is used for infectious diarrhoea and giardiasis. Learn more from the PubChem compound record.
Available Furazolidone Formulations
Our current Furazolidone portfolio spans 4 Furazolidone formulations available in the following forms: Tablets. Every batch is quality tested and released under WHO-GMP controls to ensure uniform quality across supply cycles.
Therapeutic Applications
Furazolidone is indicated for bacterial and protozoal diarrhoea, giardiasis and cholera. It is prescribed by general physicians, gastroenterologists and paediatricians and is dispensed strictly on prescription under qualified medical supervision.
Why Furazolidone is a High-Potential Molecule for Distributors
Gastrointestinal infections are common across India, and an established anti-diarrhoeal like furazolidone offers steady, affordable volume for broad-line distributors.
Why Choose Cafoli Lifecare
Partners receive district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs, and the backing of a network of 1000+ franchise partners across India. Our supply reliability and compliance-first approach help you build a durable Furazolidone franchise business.
References
- PubChem: Furazolidone
- MedlinePlus: Furazolidone
- PubMed: Furazolidone research
Our formulations of Furazolidone find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: